Trump announces deals with Eli Lilly and Novo Nordisk to sell obesity drugs for as low as $149 monthly and expand limited Medicare coverage in exchange for tariff breaks and expedited federal drug reviews.
Disease plus obesity required for coverage
From the November 6, 2025 GovBrief, every story that day in one place.